Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys

scientific article published on June 2004

Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/ART.20419
P698PubMed publication ID15188338
P5875ResearchGate publication ID8519435

P2093author name stringJ W J Bijlsma
J W G Jacobs
E Buskens
H Verkleij
S M M Verstappen
Utrecht Rheumatoid Arthritis Cohort Study Group
E J ter Borg
A A M Blaauw
P2860cites workUpdate on work disability in rheumatic diseasesQ34165685
Labour force participation among patients with rheumatoid arthritisQ35549454
Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritisQ35549946
The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patientsQ35550247
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).Q35551485
P433issue3
P921main subjectdisabilityQ12131
rheumatoid arthritisQ187255
P304page(s)488-497
P577publication date2004-06-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleOverview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys
P478volume51

Reverse relations

cites work (P2860)
Q3376636714-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage
Q52632592A Systematic Review about the Efficacy and Safety of Tripterygium wilfordii Hook.f. Preparations Used for the Management of Rheumatoid Arthritis.
Q55100474Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania.
Q23912220Beyond return to work: testing a measure of at-work disability in workers with musculoskeletal pain
Q36773202Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
Q81658201COMET's path, and the new biologicals in rheumatoid arthritis
Q48915370Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis
Q81658198Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Q36810173Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.
Q51906908Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial.
Q33413158Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort
Q26741224Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease
Q38780142Education and Employment Participation in Young Adulthood. What Role Does Arthritis Play?
Q42624729Effect of Adalimumab on Work Ability Assessed in Rheumatoid Arthritis Disease Patients in Saudi Arabia (AWARDS).
Q38127400Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals
Q38689012Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials
Q36183792Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study
Q36843031Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.
Q54486804Experiences of employment among young people with juvenile idiopathic arthritis: a qualitative study.
Q57995059Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA
Q55098455Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients.
Q79772056Functional staging and surgical intervention of the elbow and shoulder joints in a patient with rheumatoid arthritis
Q34805081Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts
Q35579507Health economics: implications for novel antirheumatic therapies
Q31043066Health status, activity limitations, and disability in work and housework among Latinos and non-Latinos with arthritis: an analysis of national data
Q37031429Illness intrusion and psychological adjustment to rheumatic diseases: a social identity framework
Q45279742Impact of ankylosing spondylitis on work in patients across the UK.
Q55018924Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort.
Q39257920Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Q31019080Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
Q44373707Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis
Q57146485Negotiating disability in everyday life: ethnographical accounts of women with rheumatoid arthritis
Q37639498One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis: Results of a Randomized Controlled Trial
Q38046771Patients with well-established ankylosing spondylitis show limited deterioration in a ten-year prospective cohort study.
Q35637390Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment
Q80814319Physical activity prevents bone loss in premenopausal women with rheumatoid arthritis: a cohort study
Q34117111Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol
Q38683116Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years
Q89876454Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis
Q31107489Prevalence and correlates of arthritis-attributable work limitation in the US population among persons ages 18-64: 2002 National Health Interview Survey Data
Q35637284Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis
Q47109653Prevalence, impact and care of foot problems in people with rheumatoid arthritis: results from a United Kingdom based cross-sectional survey
Q37140108Process Evaluation of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis
Q35555089Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
Q50616014Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis.
Q40180629Quality of care of rural rheumatoid arthritis patients in Austria
Q47553009Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis
Q46017740Randomized prospective study of a work place ergonomic intervention for individuals with rheumatoid arthritis and osteoarthritis.
Q80229943Rheumatoid arthritis: a primer for pharmacists
Q92092797Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study
Q36166120Sick leave and work disability in patients with early arthritis
Q45272999Sick leave as a predictor of job loss in patients with chronic arthritis
Q33767877Sick leave patterns in common musculoskeletal disorders--a study of doctor prescribed sick leave.
Q35954686Socioeconomic and employment status of patients with rheumatoid arthritis in Korea
Q33984991Striking a balance: work-health-personal life conflict in women and men with arthritis and its association with work outcomes
Q37107862Surgery Insight: orthopedic treatment options in rheumatoid arthritis
Q39904758Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.
Q35683446Tension at the borders: perceptions of role overload, conflict, strain and facilitation in work, family and health roles among employed individuals with arthritis
Q23918715The association between rheumatoid arthritis related structural changes in hands and computer keyboard operation
Q48075422The burden of disease in rheumatoid arthritis
Q37848120The burden of illness of rheumatoid arthritis
Q36885296The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort
Q30836343The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study.
Q37251489The impact of rheumatoid arthritis and biologics on employers and payers.
Q50945018The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional study.
Q53234940The international classification for functioning, disability and health. A challenge and a need for rheumatology.
Q37204693Thermal rehabilitation and osteoarticular diseases of the elderly
Q38960132Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapy
Q35065233Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.
Q53369582Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Q33714787Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers
Q51129676Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Q58805834Work Ability and Employment in Rheumatoid Arthritis: A Cross-Sectional Study on the Role of Muscle Strength and Lower Extremity Function
Q48913303Work ability: a new outcome measure in rheumatoid arthritis?
Q57030815Work disability and its determinants in patients with pituitary tumor-related disease
Q37595991Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort
Q40360229Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register
Q36985736Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores.
Q51770477Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina.
Q33871651Work dynamics among persons with systemic lupus erythematosus
Q51287268Work instability and financial loss in early inflammatory arthritis.
Q50661536Work productivity loss in early arthritis during the first 3 years of disease: a study from a French National Multicenter Cohort.
Q33990812Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.

Search more.